Doug Godshall currently serves as President and CEO of Shockwave Medical, an early commercial stage company which specializes in the treatment of severe cardiovascular calcification via catheter delivered, shockwave lithotripsy. Prior to Shockwave, Doug was most recently the Chief Executive Officer and a director of HeartWare International, Inc., a leader in the LVAD market where he served for 10 years until the company was acquired by Medtronic in August of 2016 for $1.1B. Prior to HeartWare, he held various executive and leadership positions at Boston Scientific, including President of the Vascular Surgery Division, a member of Boston Scientific’s Operating Committee and had previously served as Vice President, Business Development where he was responsible for more than 70 transactions, many of which were in the arenas of coronary and peripheral interventions. Mr. Godshall holds an MBA from Northeastern University and a BA in Economics from Lafayette College.